Vera Therapeutics (VERA) had the highest return between January 22, 2024 and February 5, 2024 by a small-cap US stock, returning 138.5%.
| ASSET | DATE | % RETURN |
|---|---|---|
Vera Therapeutics (VERA) | 1/22/2024 - 2/5/2024 | 138.47% |
Gorilla Technology (GRRR) | 1/22/2024 - 2/5/2024 | 116.83% |
ADC Therapeutics (ADCT) | 1/22/2024 - 2/5/2024 | 107.39% |
Clene (CLNNW) | 1/22/2024 - 2/5/2024 | 106.72% |
4D Molecular Therapeutics (FDMT) | 1/22/2024 - 2/5/2024 | 86.76% |
Akso Health Group ADR (AHG) | 1/22/2024 - 2/5/2024 | 83.61% |
Astria Therapeutics (ATXS) | 1/22/2024 - 2/5/2024 | 80.31% |
Mercurity Fintech Holding Inc ADR (MFH) | 1/22/2024 - 2/5/2024 | 75.61% |
Arcutis Biotherapeutics (ARQT) | 1/22/2024 - 2/5/2024 | 75% |
SEALSQ (LAES) | 1/22/2024 - 2/5/2024 | 68.64% |
QuantaSing Group Limited American Depositary Shares (QSG) | 1/22/2024 - 2/5/2024 | 59.34% |
Lexicon Pharmaceuticals (LXRX) | 1/22/2024 - 2/5/2024 | 58.91% |
Cullinan Oncology LLC (CGEM) | 1/22/2024 - 2/5/2024 | 54.24% |
Dianthus Therapeutics (DNTH) | 1/22/2024 - 2/5/2024 | 52.69% |
Plug Power (PLUG) | 1/22/2024 - 2/5/2024 | 52.46% |
Y mAbs Therapeutics (YMAB) | 1/22/2024 - 2/5/2024 | 45.74% |
POET Technologies (POET) | 1/22/2024 - 2/5/2024 | 42.71% |
Edgewise Therapeutics (EWTX) | 1/22/2024 - 2/5/2024 | 40.21% |
Dyne Therapeutics (DYN) | 1/22/2024 - 2/5/2024 | 40.17% |
GigaCloud Technology Inc Class A Ordinary Shares (GCT) | 1/22/2024 - 2/5/2024 | 39.89% |
Larimar Therapeutics (LRMR) | 1/22/2024 - 2/5/2024 | 39.16% |
Kura Oncology (KURA) | 1/22/2024 - 2/5/2024 | 38.95% |
Mineralys Therapeutics, Inc Common Stock (MLYS) | 1/22/2024 - 2/5/2024 | 38.28% |
Compass Pathways (CMPS) | 1/22/2024 - 2/5/2024 | 37.11% |
Intuitive Machines (LUNR) | 1/22/2024 - 2/5/2024 | 35.06% |
Small-cap stocks are treated as having a market cap between $300M and $2B.
